Related Experiment Video

Updated: Oct 3, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.8K

Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights

Bhawna Uprety1, Heidi Abrahamse1

  • 1Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein 2028, South Africa.

Cells
|February 15, 2022
PubMed

Insights

Metformin and vanadium compounds activate AMPK, a key target for cancer stem cell therapy. This review explores vanadium

Area of Science:

  • Oncology and Pharmacology
  • Metabolic Disease Research

Background:

  • Breast cancer is the most prevalent globally, with cancer stem cells driving treatment failure and metastasis.
  • Targeting cancer stem cells alongside bulk tumor cells is crucial for effective breast cancer therapy.
  • Non-oncology drugs, like metformin, show promise for anticancer activities by targeting cancer stem cell pathways.

Purpose of the Study:

  • To review the potential of insulin-mimetic vanadium compounds in treating breast cancer.
  • To explore the role of vanadium compounds in targeting cancer stem cells via AMPK activation and PTP1B inhibition.

Main Methods:

  • Literature review focusing on metformin's mechanism via AMPK activation.
  • Analysis of vanadium compounds' properties as PTP inhibitors and AMPK activators.
  • Exploration of existing research on vanadium compounds in metabolic diseases.

Main Results:

  • Metformin activates AMPK, inhibiting pathways crucial for cancer stem cell maintenance.
  • Vanadium compounds are known PTP1B inhibitors and AMPK activators, with applications in diabetes.
  • The potential of vanadium compounds in targeting breast cancer stem cells remains largely unexplored.

Conclusions:

  • AMPK activation is a promising strategy for targeting cancer stem cells in breast cancer.
  • Vanadium compounds, due to their PTP1B inhibitory and AMPK activating properties, represent a potential therapeutic avenue for breast cancer.
  • Further research is warranted to investigate the efficacy of vanadium compounds against breast cancer stem cells.
Keywords:
AMPK activationcancer stem cellsnon-oncology drugsvanadium

More Related Videos

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

4.7K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K